Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time-to-event endpoints

DOI10.1002/SIM.10191MaRDI QIDQ6652628zbMATH OpenFDO

Authors Matthias Kormaksson, Markus Reiner Lange, David Demanse, Susanne Strohmaier, Jiawei Duan, Qing Xie, Mariana Carbini, Claudia Bossen, Achim Guettner, Antonella Maniero

Publication date 12 December 2024

Published in Statistics in Medicine (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/SIM.10191

zbMATH Keywords

direct effectsdynamic path analysisindirect effectstotal effects

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• Causal inference in statistics: an overview
• Causality. Models, reasoning, and inference
• Defining causal mediation with a longitudinal mediator and a survival outcome
• Dynamic path analysis -- a new approach to analyzing time-dependent covariates
• ggplot2. Elegant graphics for data analysis. With contributions by Carson Sievert
• scientific article; zbMATH DE number 3696328 (Why is no real title available?)
• scientific article; zbMATH DE number 1834429 (Why is no real title available?)
• Mediation analysis of time-to-event endpoints accounting for repeatedly measured mediators subject to time-varying confounding
• Mediation Analysis with time Varying Exposures and Mediators
• Subtleties in the interpretation of hazard contrasts
• Survival and event history analysis. A process point of view
• The method of path coefficients.
• Time‐dependent mediators in survival analysis: Modeling direct and indirect effects with the additive hazards model

Cited in

(2)

• Survival analysis under the Aalen's additive hazards model with covariate measurement error: application to causal mediation analysis
• Randomized interventional effects in semicompeting risks, with application to a hematopoietic cell transplantation study

This page was built for publication: Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time-to-event endpoints

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6652628)